Brief: China Regenerative Medicine International Ltd updates on termination negotiation of proposed transaction
19/12/2016 11:09
Dec 19 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK
* HKLST and CRMI had decided to terminate negotiation of
proposed transaction on 18 december 2016.
* Reference is made to announcement dated 17 august by hong
kong life sciences and and china regenerative medicine
* Termination does not have any material adverse impact on
financial position and business operation of hklst group and
crmi group
Source text for Eikon: ID:nHKS93gy41
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital